ADAM17 Fluorogenic Assay Kit
The key to the ADAM17 Fluorescent Assay Kit is the fluorogenic substrate. Using this kit, only one simple step on a microtiter plate is required for ADAM17 reactions. A sample containing ADAM17 is incubated in a reaction mixture with the fluorogenic substrate and fluorescence (λex = 485 nm, λem = 530 nm) is measured using a plate reader.
Need us to run inhibitor screens or profile your compounds against ADAM17? Check out our Protease Screening Services.
This product has been cited 1 time.
Luminometer or fluorescent microplate reader capable of reading chemiluminescence
Adjustable micropipettor and sterile tips
Rotating or rocker platform
Catalog # | Component | Amount | Storage | |
ADAM17 | 3 µg | -80°C | Avoid freeze/ thaw cycles! |
|
ADAM Fluorogenic Substrate (1 mM) | 50 µl | -80°C | ||
78001 | 1X ADAM Assay Buffer | 5 ml | -20°C | |
79685 | 96-well black plate | 1 | Room Temp |
ADAM17 (ADAM Metallopeptidase Domain 17) is part of the ADAM family of disintegrins and metalloproteases. Initially identified as TNF-α converting enzyme (TACE), ADAM 17 has been linked to a number of diverse signaling pathways. It cleaves ectodomains of various transmembrane proteins and regulates cytokine shedding. It also plays a role in inflammatory skin and bowel disease.
1. Scheller, Jürgen, et al. 2011. "ADAM17: a molecular switch to control inflammation and tissue regeneration." Trends in Immunology 32(8): 380-387.
2. Blaydon, Diana C., et al. 2011. "Inflammatory skin and bowel disease linked to ADAM17 deletion." New England Journal of Medicine 365(16): 1502-1508.